Peter W. Janes
- Molecular Biology top 5%
- Cellular and Molecular Neuroscience top 2%
- Cell Biology top 1%
- Oncology top 5%
- Immunology top 5%
- Co-authors
- Anthony I. MageeSteven C. LeyMartin LackmannRobert L. SutherlandRoger J. DalyEva NievergallPanagiotis S. KabouridisDimitar B. Nikolov
- Topics
- Axon Guidance and Neuronal Signaling (24 papers)HER2/EGFR in Cancer Research (16 papers)Hippo pathway signaling and YAP/TAZ (13 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Peter W. Janes
42 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 2.1k
- Cellular and Molecular Neuroscience 982
- Cell Biology 837
- Oncology 740
- Immunology 675
Countries citing papers authored by Peter W. Janes
This map shows the geographic impact of Peter W. Janes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Janes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Janes more than expected).
Fields of papers citing papers by Peter W. Janes
This network shows the impact of papers produced by Peter W. Janes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Janes. The network helps show where Peter W. Janes may publish in the future.
Co-authorship network of co-authors of Peter W. Janes
This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Janes. A scholar is included among the top collaborators of Peter W. Janes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Janes. Peter W. Janes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospectsbreakdown → | 29 |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 123 | |
| 7 | 67 | |
| 8 | 18 | |
| 9 | 4 | |
| 10 | 43 | |
| 11 | 76 | |
| 12 | 75 | |
| 13 | 208 | |
| 14 | 35 | |
| 15 | 107 | |
| 16 | 116 | |
| 17 | 376 | |
| 18 | 81 | |
| 19 | 61 | |
| 20 | 111 |
About Peter W. Janes
Peter W. Janes is a scholar working on Cellular and Molecular Neuroscience, Cell Biology and Oncology, having authored 42 papers that have together received 3.4k indexed citations. Recurring topics across this work include Axon Guidance and Neuronal Signaling (24 papers), HER2/EGFR in Cancer Research (16 papers) and Hippo pathway signaling and YAP/TAZ (13 papers). The work is most often cited by research in Immunology and Allergy (337 citations), Cellular and Molecular Neuroscience (982 citations) and Cell Biology (837 citations). Peter W. Janes has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Anthony I. Magee, Steven C. Ley, Martin Lackmann, Robert L. Sutherland, Roger J. Daly, Eva Nievergall, Panagiotis S. Kabouridis, Dimitar B. Nikolov, Anna DeFazio and Sabine Wimmer-Kleikamp. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.